Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
Rachel I. Anderson, Howard C. Becker, Benjamin L. Adams, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 108
To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance
Juliette A. Brown, Hillary L. Woodworth, Gina M. Leinninger
Frontiers in Systems Neuroscience (2015) Vol. 9
Open Access | Times Cited: 95
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
Brain Research (2016) Vol. 1654, pp. 34-42
Open Access | Times Cited: 88
Recent Perspectives on Sex Differences in Compulsion-Like and Binge Alcohol Drinking
Anna K. Radke, Elizabeth A. Sneddon, Raizel M. Frasier, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 85
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1
Courtney D. Prince, Andrew R. Rau, Jordan T. Yorgason, et al.
ACS Chemical Neuroscience (2014) Vol. 6, Iss. 1, pp. 138-146
Open Access | Times Cited: 80
Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis
Brian A. Baldo
Trends in Neurosciences (2016) Vol. 39, Iss. 6, pp. 366-377
Open Access | Times Cited: 75
Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice
Rachel I. Anderson, Marcelo F. Lopez, William C. Griffin, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 6, pp. 1084-1092
Open Access | Times Cited: 69
Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
European Journal of Neuroscience (2016) Vol. 43, Iss. 5, pp. 710-720
Open Access | Times Cited: 67
The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
Marcelo F. Lopez, David E. Moorman, Gary Aston‐Jones, et al.
Brain Research (2016) Vol. 1636, pp. 74-80
Open Access | Times Cited: 66
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin‐1 receptor antagonist in rats
Morgan H. James, Hannah E. Bowrey, Colin M. Stopper, et al.
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2602-2612
Open Access | Times Cited: 64
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Animal models of compulsion alcohol drinking: Why we love quinine-resistant intake and what we learned from it
Thatiane De Oliveira Sergio, Raizel M. Frasier, F. Woodward Hopf
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 20
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Binge‐Like Consumption of Ethanol and Other Salient Reinforcers is Blocked by Orexin‐1 Receptor Inhibition and Leads to a Reduction of Hypothalamic Orexin Immunoreactivity
Jeffrey J. Olney, Montserrat Navarro, Todd E. Thiele
Alcoholism Clinical and Experimental Research (2015) Vol. 39, Iss. 1, pp. 21-29
Open Access | Times Cited: 58
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Visual attention: Linking prefrontal sources to neuronal and behavioral correlates
Kelsey Clark, Ryan Fox Squire, Yaser Merrikhi, et al.
Progress in Neurobiology (2015) Vol. 132, pp. 59-80
Open Access | Times Cited: 56
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Hypothalamic neuropeptide signaling in alcohol addiction
Jessica R. Barson, Sarah F. Leibowitz
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 65, pp. 321-329
Open Access | Times Cited: 54
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Drug addiction: An affective-cognitive disorder in need of a cure
Liana Fattore, Marco Diana
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 341-361
Closed Access | Times Cited: 49
Roles of dopamine and glutamate co‐release in the nucleus accumbens in mediating the actions of drugs of abuse
Silas A. Buck, Mary M. Torregrossa, Ryan W. Logan, et al.
FEBS Journal (2020) Vol. 288, Iss. 5, pp. 1462-1474
Open Access | Times Cited: 40
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning models
Oshin Miranda, Peihao Fan, Xiguang Qi, et al.
Drug and Alcohol Dependence (2024) Vol. 255, pp. 111066-111066
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top